rs199476360
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000487.6(ARSA):c.925G>T(p.Glu309*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000011 in 1,460,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. E309E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000487.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
- metachromatic leukodystrophyInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
- metachromatic leukodystrophy, juvenile formInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ARSA | NM_000487.6 | c.925G>T | p.Glu309* | stop_gained | Exon 5 of 8 | ENST00000216124.10 | NP_000478.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ARSA | ENST00000216124.10 | c.925G>T | p.Glu309* | stop_gained | Exon 5 of 8 | 1 | NM_000487.6 | ENSP00000216124.5 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD2 exomes AF: 0.00000406 AC: 1AN: 246094 AF XY: 0.00000749 show subpopulations
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1460356Hom.: 0 Cov.: 35 AF XY: 0.00000964 AC XY: 7AN XY: 726354 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Metachromatic leukodystrophy Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 928724). This variant is also known as c.919G>T (p.E307X). This premature translational stop signal has been observed in individual(s) with ARSA-related conditions (PMID: 18693274). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu309*) in the ARSA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ARSA are known to be pathogenic (PMID: 8962139, 10477432). -
Variant summary: ARSA c.925G>T (p.Glu309X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4.1e-06 in 246094 control chromosomes (gnomAD). c.925G>T has been reported in the literature in a compound heterozygous individual affected with Metachromatic Leukodystrophy (Grossi_2008). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at